Zemprocitinib clinical trials
Also written LNK01001.
How each study uses zemprocitinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the zemprocitinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Lynk Pharmaceuticals Co., Ltd (6)
Related medicines
As reviewed, each with the page that says it.
- One of JAK inhibitors source
- One of Protein Kinase Inhibitors source
- One of Tyrosine kinase inhibitors (TKIs) source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test zemprocitinib, phase 3 first.
- Nov 2026A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing SpondylitisPhase 3 · Lynk Pharmaceuticals Co., Ltd
Studies
Open first, then newest update. How each study uses zemprocitinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing SpondylitisRecruitingPhase 3Lynk Pharmaceuticals Co., LtdNCT07237568Written as LNK01001
- A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)CompletedPhase 3Lynk Pharmaceuticals Co., LtdNCT06276998Written as LNK01001
- A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.CompletedPhase 3Lynk Pharmaceuticals Co., LtdNCT06277245Written as LNK01001
- A Study of LNK01001 Capsule in Patients With Ankylosing SpondylitisCompletedPhase 2Lynk Pharmaceuticals Co., LtdNCT06085534Written as LNK01001
- A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic DermatitisCompletedPhase 2Lynk Pharmaceuticals Co., LtdNCT06085521Written as LNK01001 Dose A
- A Study of LNK01001 Capsule in Moderately to Severely Active Rheumatoid ArthritisCompletedPhase 2Lynk Pharmaceuticals Co., LtdNCT06099535Written as LNK01001 Dose A
Codes
What other systems call zemprocitinib · ClinicalTrials.gg INT017178
- UNII (FDA) LG6MM3RP86ZEMPROCITINIBConfirmed FDA, Wikidata
- Wikidata Q140562005zemprocitinibConfirmed FDA, Wikidata
- NCI Thesaurus C207018ZemprocitinibOne source FDA
- DrugBank DB21719One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | LG6MM3RP86 | ZEMPROCITINIB | Confirmed FDA, Wikidata |
| Wikidata | Q140562005 | zemprocitinib | Confirmed FDA, Wikidata |
| NCI Thesaurus | C207018 | Zemprocitinib | One source FDA |
| DrugBank | DB21719 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.